← Back to Search

Other

Study for Papulopustular Rosacea

N/A
Waitlist Available
Led By Peter Friedman, MD PhD
Research Sponsored by The Skin Center Dermatology Group
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights

Study Summary

This trial will test if a cold plasma device, used on one side of the face, is better than a cream for treating acne.

Eligible Conditions
  • Papulopustular Rosacea

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Demodex count change
Efficacy - Investigator global assessment
Efficacy - National Rosace Society Expert Committee grading system
+1 more
Secondary outcome measures
Tolerability - Incidence of Treatment-Emergent Adverse Events as assessed by patient review
Tolerability - pain as assessed by NRS scale

Trial Design

1Treatment groups
Experimental Treatment
Group I: StudyExperimental Treatment1 Intervention
Single arm study: split face treatment

Find a Location

Who is running the clinical trial?

The Skin Center Dermatology GroupLead Sponsor
3 Previous Clinical Trials
157 Total Patients Enrolled
Peter Friedman, MD PhDPrincipal InvestigatorThe Skin Center Dermatology Group
~0 spots leftby May 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top